These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 20859899

  • 21. Predictors of hyperkalemia risk following hypertension control with aldosterone blockade.
    Khosla N, Kalaitzidis R, Bakris GL.
    Am J Nephrol; 2009; 30(5):418-24. PubMed ID: 19738369
    [Abstract] [Full Text] [Related]

  • 22. Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone.
    Berry C, McMurray J.
    Am J Med; 2001 Nov; 111(7):587. PubMed ID: 11705445
    [No Abstract] [Full Text] [Related]

  • 23. Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases.
    Wrenger E, Müller R, Moesenthin M, Welte T, Frölich JC, Neumann KH.
    BMJ; 2003 Jul 19; 327(7407):147-9. PubMed ID: 12869459
    [No Abstract] [Full Text] [Related]

  • 24. [Ineffective atrial pacing and cardiac arrest in a 80-year old woman with hyperkalemia].
    Lelakowski J, Czunko A, Majewski J, Pasowicz M, Małecka B, Bednarek J.
    Pol Merkur Lekarski; 2005 May 19; 18(107):566-7. PubMed ID: 16161957
    [Abstract] [Full Text] [Related]

  • 25. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.
    Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J.
    N Engl J Med; 1999 Sep 02; 341(10):709-17. PubMed ID: 10471456
    [Abstract] [Full Text] [Related]

  • 26. Spironolactone for heart failure.
    Med Lett Drugs Ther; 1999 Sep 10; 41(1061):81-2. PubMed ID: 10505071
    [No Abstract] [Full Text] [Related]

  • 27. Spironolactone in patients with heart failure.
    Vanpee D, Swine C.
    N Engl J Med; 2000 Jan 13; 342(2):133; author reply 133-4. PubMed ID: 10636753
    [No Abstract] [Full Text] [Related]

  • 28. Appropriateness and complications of the use of spironolactone in patients treated in a heart failure clinic.
    Goland S, Naugolny V, Korbut Z, Rozen I, Caspi A, Malnick S.
    Eur J Intern Med; 2011 Aug 13; 22(4):424-7. PubMed ID: 21767763
    [Abstract] [Full Text] [Related]

  • 29. [The 10-minute consultation. Accidental finding: hyperkalemia. Caution with analgesics and bananas].
    Lenz T.
    MMW Fortschr Med; 2005 Jan 27; 147(4):59-60. PubMed ID: 15745346
    [No Abstract] [Full Text] [Related]

  • 30. Drug safety in patients with heart failure.
    Juurlink DN, Hansten PD.
    Arch Intern Med; 2005 Jan 10; 165(1):118. PubMed ID: 15642888
    [No Abstract] [Full Text] [Related]

  • 31. [Renal effect of treatment for heart failure].
    Rasmussen ZZ, Barfod T, Klit J.
    Ugeskr Laeger; 2009 Feb 23; 171(9):718. PubMed ID: 19257999
    [Abstract] [Full Text] [Related]

  • 32. Influence of combined angiotensin-converting enzyme inhibitors and spironolactone on serum K+, Mg 2+, and Na+ concentrations in small dogs with degenerative mitral valve disease.
    Thomason JD, Rockwell JE, Fallaw TK, Calvert CA.
    J Vet Cardiol; 2007 Nov 23; 9(2):103-8. PubMed ID: 17983885
    [Abstract] [Full Text] [Related]

  • 33. Efficacy of low dose spironolactone in chronic kidney disease with resistant hypertension.
    Abolghasmi R, Taziki O.
    Saudi J Kidney Dis Transpl; 2011 Jan 23; 22(1):75-8. PubMed ID: 21196617
    [Abstract] [Full Text] [Related]

  • 34. [Hyperkalemia, heart failure and reduced renal function].
    Bugge JF.
    Tidsskr Nor Laegeforen; 2010 Jul 01; 130(13):1354-5. PubMed ID: 20596118
    [No Abstract] [Full Text] [Related]

  • 35. Elderly heart failure patients with drug-induced serious hyperkalemia.
    Vanpee D, Swine CH.
    Aging (Milano); 2000 Aug 01; 12(4):315-9. PubMed ID: 11073352
    [Abstract] [Full Text] [Related]

  • 36. Combined use of an ACE-inhibitor and spironolactone in patients with heart insufficiency.
    Schröder J, Goltz L, Knoth H.
    Med Monatsschr Pharm; 2017 Jan 01; 40(1):24-6. PubMed ID: 29952529
    [Abstract] [Full Text] [Related]

  • 37. Spironolactone + ace inhibitor or sartan: risk of hyperkalaemia.
    Prescrire Int; 2004 Apr 01; 13(70):58. PubMed ID: 15148978
    [No Abstract] [Full Text] [Related]

  • 38. Treatment of heart failure with spironolactone--trial and tribulations.
    McMurray JJ, O'Meara E.
    N Engl J Med; 2004 Aug 05; 351(6):526-8. PubMed ID: 15295043
    [No Abstract] [Full Text] [Related]

  • 39. Serum potassium in stage 5 CKD patients on their first presentation in a dialysis service of a county hospital in western Romania.
    Gluhovschi G, Mateş A, Gluhovschi C, Golea O, Gădălean F, Somai M, Ene I, Petrica L, Velciov S.
    Rom J Intern Med; 2014 Aug 05; 52(1):30-8. PubMed ID: 25000676
    [Abstract] [Full Text] [Related]

  • 40. [Effect of aldosterone antagonism in heart failure: pharmacotherapeutic options].
    Diercks GF, Overdiek JW, van Veldhuisen DJ.
    Ned Tijdschr Geneeskd; 2001 Feb 03; 145(5):204-8. PubMed ID: 11219145
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.